PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Principles, Recent Developments and Perspectives in Boron Neutron Capture Therapy (BNCT)

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
For decades, BNCT was seen as an attractive concept and an intellectual challenge with no prospect of widespread clinical application. This situation has changed fundamentally in just a few years with the progress in accelerator technology. Low-energy, high- -intensity neutron sources can now be integrated into hospitals and are therefore directly available for patient treatment. A pioneer in this field is the development in Japan, where patients are already being treated in three hospitals, using in-house accelerator-based systems. Furthermore, the costs associated with the BNCT treatment of recurrent tumors in the head and neck area are already covered by the healthcare system. It is time to keep up to date with this technology and work to make it available to patients in high- -tech medicine in other countries, especially in Europe and North America. This short article summarizes the main principles of BNCT, outlines some aspects of its history and mentions ongoing projects as well as some hurdles that need to be overcome, as well as the scientific questions that need to be addressed for wider availability of the method.
Rocznik
Strony
48--53
Opis fizyczny
Bibliogr. 24 poz., tab.
Twórcy
  • Deutsche Gesellschaft für Bor-Neutroneneinfangtherapie DGBNCT (Strahlenklinik, Universitätsklinikum Essen), Essen, Germany
  • Neutron Therapy Research Center, Okayama University, Okayama, Japan
  • Université Grenoble Alpes, Inserm UA7, Clinique Universitaire de Cancérologie - Radiothérapie, CHU Grenoble, France
  • Deutsche Gesellschaft für Bor-Neutroneneinfangtherapie DGBNCT (Strahlenklinik, Universitätsklinikum Essen), Essen, Germany
  • Klinik und Poliklinik für Strahlentherapie und Radio-onokologie, Universitätsklinikum Würzburg, Julius-Maximilians-Universität, Würzburg, Germany
autor
  • Deutsche Gesellschaft für Bor-Neutroneneinfangtherapie DGBNCT (Strahlenklinik, Universitätsklinikum Essen), Essen, Germany
  • Université Grenoble Alpes, INSERM U1209 CNRS UMR 5309, Institute for Advanced Biosciences, Grenoble, France
  • Université Grenoble Alpes, Inserm UA7, Clinique Universitaire de Cancérologie - Radiothérapie, CHU Grenoble, France
  • Neutron Therapy Research Center, Okayama University, Okayama, Japan
  • Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Japan
  • BNCT Global GmbH, Essen, Germany
  • Deutsche Gesellschaft für Bor-Neutroneneinfangtherapie DGBNCT (Strahlenklinik, Universitätsklinikum Essen), Essen, Germany
  • Klinik und Poliklinik für Strahlentherapie und Radio-onokologie, Universitätsklinikum Würzburg, Julius-Maximilians-Universität, Würzburg, Germany
Bibliografia
  • 1. Sauerwein W. Principles and roots of neutron capture therapy. In: Sauerwein W, Wittig A, Moss R, Nakagawa Y, editors. Neutron Capture Therapy. Principles and Applications. Heidelberg: Springer; 2012. p. 1-16. doi: 10.1007/978-3-642-31334-9.
  • 2. International Commission on Radiation Units and Measurements, Stephen M. ICRU Report 85: Fundamental Quantities and Units for Ionizing Radiation. ICRU, 2011;11:1-31. doi: 10.1093/jicru/ndr012.
  • 3. Barendsen GW. The relationships between RBE and LET for different types of lethal damage in mammalian cells: biophysical and molecular mechanisms. Radiation Res. 1994;139:257-70.
  • 4. Goodhead DT. Mechanisms for the biological effectiveness of high-LET radiations. J Radiat Res. 1999;40(Suppl):S1-13. doi: 10.1269/jrr.40.s1.
  • 5. Kellert M, Hey-Hawkins E. DGBNCT-Boron Agents. [Internet]. Available from: https://dgbnct.com/index.php/boron-agents/.
  • 6. Sauerwein WAG, Sancey L, Hey-Hawkins E, Kellert M, Panza L, Imperio D, et al. Theranostics in Boron Neutron Capture Therapy. Life 2021;11(4):330. doi: doi.org/10.3390/life11040330.
  • 7. Kwiatkowska A, Sobczak M, Mikolajczyk B, Janczak S, Olejniczak AB, Sochacki M, et al. SiRNAs modified with boron cluster and their physicochemical and biological characterization. Bioconjug Chem. 2013;24(6):1017-26.
  • 8. Raitano A, Martin T, Zhang C, Malinao M-C, Capo L, Ikeura M, et al. Boronotyrosine, a Borylated amino acid mimetic with enhanced solubility, tumor boron delivery, and retention for the reemerging boron neutron capture therapy field. J. Med. Chem. 2023;66:13809-20.
  • 9. Nigg D. Physical dosimetry and spectral characterization of neutron sources for neutron capture therapy. In: Sauerwein W, Wittig A, Moss R, Nakagawa Y, editors. Neutron Capture Therapy. Principles and Applications. Heidelberg: Springer; 2012. p. 227-58. doi: 10.1007/978-3-642-31334-9.
  • 10. Rassow J., Sauerwein W.: Prescribing, recording and reporting of BNCT. In: Sauerwein W, Wittig A, Moss R, Nakagawa Y, editors. Neutron Capture Therapy. Principles and Applications. Heidelberg: Springer; 2012. p. 277-86. doi: 10.1007/978-3-642-31334-9.
  • 11. Sauerwein WAG. Reporting Dose in Boron Neutron Capture Therapy. Cancer Biother Radiopharm 2023;38:192-4. doi: 10.1089/cbr.2022.0073.
  • 12. Chadwick J. The existence of a neutron. Proc R Soc London A 1932;136:692-708.
  • 13. Taylor HJ, Goldhaber M. Detection of nuclear disintegration in a photographic emulsion. Nature (London) 1935;135:341-8.
  • 14. Locher GL. Biological effects and therapeutic possibilities of neutrons. Am J Roentgenol Radium Ther 1936;36(1):1-13.
  • 15. Soloway AH, Hatanaka H, Davis MA. Penetration of brain and brain tumor. VII. Tumor binding sulfhydryl boron compounds. J Med Chem 1967;10:714-7.
  • 16. Hatanaka T. Future possibility of neutron capture therapy of malignant tumors by use of low energy neutron from nuclear reactors and other sources. Gan No Rinsho 1969;15(4):367-9.
  • 17. Hatanaka H. Clinical results of boron neutron capture therapy. Basic Life Sci 1990;54(15):15-21.
  • 18. Kankaanranta L, Seppala T, Koivunoro H, Saarilahti K, Atula T, Collan J, et al. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69:475-82.
  • 19. Koivunoro H, Kankaanranta L, Seppala T, Haapaniemi A, Mäkitie A, Joensuu H. Boron neutron capture therapy for locally recurrent head and neck squamous cell carcinoma: An analysis of dose response and survival. Radiother Oncol. 2019;137:153-8.
  • 20. Suzuki MI, Kato I, Aihara T, Hiratsuka J, Yoshimura K, Niimi M. Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer. J Radiat Res 2014;55:146-53.
  • 21. Sauerwein WAG, Ulcar M. Overview of Boron Neutron Capture Therapy in 2022. Cancer Biother Radiopharm 2023;38:143-7. doi: 10.1089/ cbr.2022.0072.
  • 22. Porra L, Wendland L, Seppälä T, Koivunoro H, Revitzer H, Tervonen J, et al. From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience. Cancer Biother Radiopharm 2023;38(3):184-91.
  • 23. Rossi S, Serra A. The boron neutron capture therapy project at CNAO. Pavia: Fondazione CNAO; 2023.
  • 24. Wittig A, Sauerwein WAG. Strategic clinical trial design for Boron Neutron Capture Therapy. Cancer Biother Radiopharm 2023;38:195-200. doi: https://doi.org/10.1089/cbr.2022.0074.
Uwagi
Opracowanie rekordu ze środków MEiN, umowa nr SONP/SP/546092/2022 w ramach programu "Społeczna odpowiedzialność nauki" - moduł: Popularyzacja nauki i promocja sportu (2022-2023).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-f26d16af-ef60-4293-899d-5a1f670689f8
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.